Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal ganglion cell | 4 studies | 39% ± 21% | |
glutamatergic neuron | 4 studies | 23% ± 7% | |
neuron | 3 studies | 39% ± 14% | |
retinal cone cell | 3 studies | 25% ± 5% | |
GABAergic neuron | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of DPYSL4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2609.58 | 2642 / 2642 | 99% | 77.48 | 700 / 705 |
prostate | 91% | 700.15 | 222 / 245 | 81% | 16.51 | 406 / 502 |
adrenal gland | 47% | 226.04 | 121 / 258 | 84% | 25.93 | 194 / 230 |
eye | 0% | 0 | 0 / 0 | 99% | 29.81 | 79 / 80 |
skin | 35% | 226.59 | 641 / 1809 | 60% | 13.15 | 284 / 472 |
ovary | 73% | 652.27 | 131 / 180 | 22% | 2.37 | 96 / 430 |
heart | 93% | 1669.99 | 797 / 861 | 0% | 0 | 0 / 0 |
uterus | 53% | 370.30 | 90 / 170 | 22% | 6.99 | 102 / 459 |
breast | 34% | 153.83 | 155 / 459 | 26% | 3.49 | 290 / 1118 |
lung | 24% | 99.04 | 140 / 578 | 26% | 4.05 | 299 / 1155 |
esophagus | 26% | 127.84 | 378 / 1445 | 22% | 2.55 | 40 / 183 |
thymus | 18% | 72.82 | 120 / 653 | 26% | 2.71 | 160 / 605 |
pancreas | 4% | 13.40 | 14 / 328 | 40% | 4.34 | 72 / 178 |
bladder | 10% | 45.38 | 2 / 21 | 17% | 3.46 | 87 / 504 |
intestine | 20% | 84.27 | 198 / 966 | 6% | 0.64 | 30 / 527 |
spleen | 22% | 83.60 | 54 / 241 | 0% | 0 | 0 / 0 |
adipose | 22% | 109.62 | 268 / 1204 | 0% | 0 | 0 / 0 |
kidney | 10% | 44.13 | 9 / 89 | 11% | 1.55 | 96 / 901 |
stomach | 16% | 68.60 | 59 / 359 | 4% | 0.44 | 12 / 286 |
muscle | 20% | 68.06 | 158 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 16% | 77.00 | 211 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 1.21 | 6 / 45 |
peripheral blood | 8% | 51.90 | 72 / 929 | 0% | 0 | 0 / 0 |
liver | 1% | 4.28 | 3 / 226 | 5% | 0.48 | 19 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007399 | Biological process | nervous system development |
GO_0006208 | Biological process | pyrimidine nucleobase catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0004157 | Molecular function | dihydropyrimidinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0031005 | Molecular function | filamin binding |
GO_0016812 | Molecular function | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides |
Gene name | DPYSL4 |
Protein name | Dihydropyrimidinase like 4 Dihydropyrimidinase-related protein 4 (DRP-4) (Collapsin response mediator protein 3) (CRMP-3) (UNC33-like phosphoprotein 4) (ULIP-4) |
Synonyms | ULIP4 CRMP3 |
Description | FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration (By similarity). . |
Accessions | O14531 ENST00000368627.1 Q5T0Q6 ENST00000338492.9 |